Russia Launches State-Owned Biopharma Giant to Boost Animal Health
Russia Launches State-Owned Biopharma Giant to Boost Animal Health
RUSSIAN BIOPHARMACEUTICAL COMPANY TO CONSOLIDATE NATION'S LEADING BIOFACTORIES
Russia Launches State-Owned Biopharma Giant to Boost Animal Health
A major Russian biopharmaceutical company will bring together the country's top biofactories to develop new veterinary drugs, including vaccines against highly dangerous diseases, TASS reports, citing the Russian Ministry of Agriculture.
The initiative, launched under a presidential decree, aims to ensure technological sovereignty and sustainable growth in the sector.
In a statement, the ministry emphasized that the consolidation will bolster Russia's technological independence, stimulate investment in veterinary science, and strengthen the domestic biotech industry.
"This is a critical step toward enhancing biological security and expanding our own technological capabilities," the ministry noted.
The new entity, established under a July 2025 presidential order, will integrate the Shchyolkovo Biocombinate, as well as the biofactories in Armavir, Kursk, Oryol, and Stavropol. The move is expected to pool industrial and research expertise, accelerating the development of innovative solutions for the industry.
Key objectives of the consolidated structure include advancing biotechnology, producing veterinary medications, and conducting research. Particular focus will be placed on anti-epizootic measures, including the development of vaccines against high-risk diseases.
Oleg Akinin, director of the Shchyolkovo Biocombinate, highlighted the rapid pace and fierce competition in the veterinary drug market.
"Above all, this drives market players to continuously improve efficiency, respond swiftly to external changes, and prioritize high-tech, science-intensive products that meet consumer demand," he explained.
Earlier, on March 30, 2026, Russian President Vladimir Putin signed a decree establishing the joint-stock company Russian Biological Industrial Company, with all shares to remain in federal ownership.
Vietnam's TIMEC Secures Loan to Expand Women-Led Healthcare Services
A bold step for gender-smart healthcare in Vietnam. TIMEC's new funding aims to upgrade facilities and reach more patients—while empowering women leaders.
Astral Systems lands £28M to fast-track fusion energy and medical isotopes
A breakthrough in clean energy and healthcare is closer than ever. With fresh funding, this fusion pioneer is racing to revolutionize reactors—and save lives.
Rising UV radiation fuels skin cancer surge in Germany by 2023
The sun's invisible threat grows deadlier each year. With UV rays penetrating deeper, are you applying enough sunscreen—or the right kind?
New Evidence Map Reveals Gaps in Healthy Ageing Interventions for Older Adults
What really works to keep older adults independent and thriving at home? A sweeping new analysis uncovers surprising gaps—and opportunities—in global ageing research. Most studies focus on mobility and basic needs, but social ties and financial security remain overlooked.